Relenza and Tacrolimus drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Relenza (zanamivir) and Tacrolimus (tacrolimus). Common drug interactions include hepatitis among females and arthralgia among males.

The phase IV clinical study analyzes what interactions people have when they take Relenza and Tacrolimus. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Relenza?

Relenza has active ingredients of zanamivir. It is often used in the flu. eHealthMe is studying from 3,738 Relenza users. Check the latest studies of Relenza.

What is Tacrolimus?

Tacrolimus has active ingredients of tacrolimus. It is often used in kidney transplant. eHealthMe is studying from 116,160 Tacrolimus users. Check the latest studies of Tacrolimus.

On Jul, 21, 2026

14 people who take Relenza and Tacrolimus together, and have interactions are studied.

Relenza and Tacrolimus drug interactions.

What are the common drug interactions of Relenza and Tacrolimus, by gender? *:

female:

Hepatitis (inflammation of the liver)
Pulmonary fibrosis (formation or development of excess fibrous connective tissue (fibrosis) in the lungs)

male:

Arthralgia (joint pain)
Back pain
Pneumonia
Blood fibrinogen decreased
Coagulopathy (blood's ability to clot is impaired)
Cushingoid (obesity and weakening of the muscles)
Cytokine storm (over-protective immune response that can actually be fatal)
Dental caries
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Gastroenteritis (inflammation of stomach and intestine)

What are the common drug interactions of Relenza and Tacrolimus, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Renal impairment (severely reduced kidney function)

10-19:

Dyspnoea exertional (breathlessness or shortness of breath)
Osteoporosis (bones weak and more likely to break)
Systolic dysfunction (impaired ventricular contraction)
Tachycardia (a heart rate that exceeds the range of 100 beats/min)
Blood fibrinogen decreased
Coagulopathy (blood's ability to clot is impaired)
Cushingoid (obesity and weakening of the muscles)
Cytokine storm (over-protective immune response that can actually be fatal)
Dental caries
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)

20-29:

n/a

30-39:

Hepatitis (inflammation of the liver)

40-49:

Pathogen resistance
Pneumonia

50-59:

n/a

60+:

Pulmonary fibrosis (formation or development of excess fibrous connective tissue (fibrosis) in the lungs)

What are the existing conditions these people have? *

Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 4 people, 28.57%
Juvenile Rheumatoid Arthritis (joint inflammation in children due to systemic disease): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Relenza and Tacrolimus?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously